LPIN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.866200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.960100E-02
Normal-vs-Stage2
3.571800E-01
Normal-vs-Stage3
4.423800E-02
Normal-vs-Stage4
3.977600E-01
Stage1-vs-Stage2
5.230500E-02
Stage1-vs-Stage3
1.373170E-01
Stage1-vs-Stage4
4.459400E-01
Stage2-vs-Stage3
1.685400E-01
Stage2-vs-Stage4
9.352600E-01
Stage3-vs-Stage4
1.501780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.445620E-01
Normal-vs-AfricanAmerican
9.491600E-01
Normal-vs-Asian
8.809400E-01
Caucasian-vs-AfricanAmerican
5.484800E-01
Caucasian-vs-Asian
5.006000E-01
AfricanAmerican-vs-Asian
9.203600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.749200E-01
Normal-vs-Female
3.147800E-01
Male-vs-Female
8.578600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.954600E-01
Normal-vs-Age(41-60Yrs)
6.113800E-01
Normal-vs-Age(61-80Yrs)
1.204200E-01
Normal-vs-Age(81-100Yrs)
1.171190E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.152400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.359400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.419400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.877600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.628610E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.974400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.993000E-01
Normal-vs-Daily Drinker
5.982100E-02
Normal-vs-Weekly Drinker
6.073500E-02
Normal-vs-Occasional Drinker
1.771410E-01
Normal-vs-Social Drinker
1.214050E-01
Non Drinker-vs-Daily Drinker
1.144590E-01
Non Drinker-vs-Weekly Drinker
9.468100E-02
Non Drinker-vs-Occasional Drinker
2.619400E-01
Non Drinker-vs-Social Drinker
3.021600E-01
Daily Drinker-vs-Weekly Drinker
7.770000E-01
Daily Drinker-vs-Occasional Drinker
6.320800E-01
Daily Drinker-vs-Social Drinker
4.650600E-01
Weekly Drinker-vs-Occasional Drinker
5.145800E-01
Weekly Drinker-vs-Social Drinker
3.589200E-01
Occasional Drinker-vs-Social Drinker
8.536600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.020400E-01
Normal-vs-Grade 2
1.102420E-01
Normal-vs-Grade 3
1.062010E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.848400E-01
Grade 1-vs-Grade 3
5.972600E-01
Grade 1-vs-Grade 4
2.020400E-01
Grade 2-vs-Grade 3
4.161400E-01
Grade 2-vs-Grade 4
1.102420E-01
Grade 3-vs-Grade 4
1.062010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.770400E-02
Normal-vs-NonDiabetic
3.435400E-01
Diabetic-vs-NonDiabetic
1.050190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.687000E-01
Normal-vs-NoPancreatitis
1.550430E-01
Pancreatitis-vs-NoPancreatitis
6.188600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.682600E-01
Normal-vs-N1
2.365200E-01
N0-vs-N1
5.900400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.312000E-01
Normal-vs-TP53-NonMutant
3.814000E-01
TP53-Mutant-vs-TP53-NonMutant
6.292400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
